SOLANA BEACH, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation
SOLANA BEACH, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation
ClearPoint Neuro's (CLPT) receipt of the FDA's latest approval is likely to provide fast, peri-procedural segmentation of the cortical structures of the brain.
Finding a quality up-and-coming stock is a tricky proposition, but doubly so now that we're well past the ZIRP-era “stocks go up” sentiment. In the past, you could throw capital at any up-and-comi

ClearPoint Neuro: Potential Inflection Point

08:19am, Thursday, 15'th Feb 2024
ClearPoint Neuro's stock has performed well over the past 4 months, supported by solid business fundamentals. Despite the move higher, ClearPoint's valuation is still modest, given the company's poten
Healthcare stocks are one of the best sectors to capture long-term innovation and sector strength. After all, healthcare needs are perennial, especially as the global population lives longer and can g
ClearPoint (CLPT) is likely to provide effective neurosurgical operations with the installation of the ClearPoint Prism Neuro Laser Therapy System and the Neuro Navigation System.
Small-cap healthcare stocks might be the next stock market goldmine, but many investors are overlooking the sector's potential. Small-cap healthcare stocks tend to be nimbler and more innovative than
ClearPoint Neuro's (CLPT) receipt of the FDA's latest approval is likely to serve a wider patient pool than its legacy portfolio.
Small-cap stocks are set to have their day in the sun this year, and not just because favorable economic and monetary policy conditions are set to put wind in their sales. Instead, investors are incre

7 Solid Small-Caps for 2024 and Beyond

09:31am, Tuesday, 05'th Dec 2023
I think 2024 will be the year small-cap stocks win big. We're already seeing tailwinds lift the stock market closer to past highs, but (valid) criticism points to just a handful of mega-cap stocks dri
ClearPoint Neuro, Inc. (NASDAQ:CLPT ) Q3 2023 Earnings Conference Call November 9, 2023 4:30 PM ET Company Participants Joe Burnett - Chief Executive Officer Danilo D'Alessandro - Chief Financial Offi
SOLANA BEACH, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the b
ClearPoint Neuro, Inc. (CLPT) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to loss of $0.18 per share a year ago.
SOLANA BEACH, Calif., July 25, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the b
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE